BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21292303)

  • 1. Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features.
    Gibson SE; Swerdlow SH; Felgar RE
    Hum Pathol; 2011 May; 42(5):679-87. PubMed ID: 21292303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
    Wu D; Thomas A; Fromm JR
    Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-tumoral cytolytic cells: pattern of distribution in B-cell non Hodgkin s lymphoma.
    Perambakam S; Naresh K; Nerurkar A; Nadkarni J
    Pathol Oncol Res; 2000; 6(2):114-7. PubMed ID: 10936786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy.
    Klanova M; Oestergaard MZ; Trněný M; Hiddemann W; Marcus R; Sehn LH; Vitolo U; Bazeos A; Goede V; Zeuner H; Knapp A; Sahin D; Spielewoy N; Bolen CR; Cardona A; Klein C; Venstrom JM; Nielsen T; Fingerle-Rowson G
    Clin Cancer Res; 2019 Aug; 25(15):4634-4643. PubMed ID: 31053601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
    Almasri NM; Iturraspe JA; Braylan RC
    Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
    Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
    J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
    Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
    Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].
    Pileri SA; Fraternali-Orcioni G; Ascani S; Piccioli M; Poggi S; Piccaluga PP; Leoncini L; Falini B
    Pathologica; 2000 Jun; 92(3):145-61. PubMed ID: 10902425
    [No Abstract]   [Full Text] [Related]  

  • 11. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human peripheral blood DNAM-1
    Stannard KA; Lemoine S; Waterhouse NJ; Vari F; Chatenoud L; Gandhi MK; Martinet L; Smyth MJ; Guillerey C
    Blood Adv; 2019 Jun; 3(11):1681-1694. PubMed ID: 31167820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
    Vari F; Arpon D; Keane C; Hertzberg MS; Talaulikar D; Jain S; Cui Q; Han E; Tobin J; Bird R; Cross D; Hernandez A; Gould C; Birch S; Gandhi MK
    Blood; 2018 Apr; 131(16):1809-1819. PubMed ID: 29449276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.
    Alikhan M; Song JY; Sohani AR; Moroch J; Plonquet A; Duffield AS; Borowitz MJ; Jiang L; Bueso-Ramos C; Inamdar K; Menon MP; Gurbuxani S; Chan E; Smith SM; Nicolae A; Jaffe ES; Gaulard P; Venkataraman G
    Mod Pathol; 2016 Oct; 29(10):1173-82. PubMed ID: 27312067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer.
    Darvishvand R; Rezaeifard S; Kiani R; Tahmasebi S; Faghih Z; Erfani N
    Immun Inflamm Dis; 2024 Apr; 12(4):e1255. PubMed ID: 38652012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
    Admirand JH; Rassidakis GZ; Abruzzo LV; Valbuena JR; Jones D; Medeiros LJ
    Mod Pathol; 2004 Aug; 17(8):954-61. PubMed ID: 15133473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer (NK) cell leukaemia in a patient with a B cell non-Hodgkin's lymphoma.
    Dekoninck A; Cartuyvels R; Magerman K; Peeters V; Mewis A; Wuyts B; Delva A; Vanstraelen D; Rummens JL
    Clin Lab Haematol; 2000 Apr; 22(2):115-7. PubMed ID: 10792403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse large B cell lymphoma expressing the natural killer cell marker CD56.
    Sekita T; Tamaru JI; Isobe K; Harigaya K; Masuoka S; Katayama T; Kobayashi M; Mikata A
    Pathol Int; 1999 Aug; 49(8):752-8. PubMed ID: 10504545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.
    Kaleem Z; White G; Zutter MM
    Am J Clin Pathol; 2001 Mar; 115(3):396-403. PubMed ID: 11242796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.